Galacto-Oligosaccharides - Prebiotics and Probiotics Ingredients - page 90

35. Moro, G. et al., Dosage related bifidogenic effects of galacto and fructo-oligosaccha-
rides in formula-fed term infants, J. Paediatr. Gastroenterol. Nutr ., 34, 291, 2002.
36. Bakker-Zierikzee, A.M. et al., Effects of infant formula containing a mixture of galacto-
and fructo-oligosaccharides or viable Bifidobacterium animalis on the intestinal micro-
flora during the first four months of life, Br. J. Nutr ., 94, 783, 2005.
37. Haarman, M. and Knol, J., Quantitative real-time PCR assays to identify and quan-
tify fecal Bifidobacterium species in infants receiving a prebiotic infant formula, Appl.
Environ. Microbiol ., 71, 2318, 2005.
38. Haarman, M. and Knol, J., Quantitative real-time PCR analysis of fecal lactobacillus spe-
cies in infants receiving a prebiotic infant formula, Appl. Environ. Microbiol ., 72, 2359,
2006.
39. Knol, J. et al., Colon microflora in infants fed formula with galacto- and fructo-oligosac-
charides: More like breast-fed infants, J. Pediatr. Gastroenterol. Nutr ., 40, 36, 2005a.
40. Knol, J. et al., Increase of fecal bifidobacteria due to dietary oligosaccharides induces
a reduction of clinically relevant pathogen germs in the faeces of formula-fed preterm
infants, Acta Paediatr ., 94, 31, 2005b.
41. Scholtens, P.A. et al., Bifidogenic effects of solid weaning foods with added prebiotic
oligosaccharides: A randomised controlled clinical trial, J. Pediatr. Gastroenterol. Nutr. ,
42(5), 553, 2006.
42. Shadid R. et al., Effects of galactooligosaccharide and long-chain fructooligosac-
charide supplementation during pregnancy on maternal and neonatal microbiota and
immunity—A randomized, double-blind, placebo-controlled study, Am. J. Clin. Nutr. ,
86, 1426, 2007.
43. Rousseau, V. et al., Prebiotic effects of oligosaccharides on selected vaginal lactobacilli
and pathogenic microorganisms, Anaerobe , 11, 145, 2005.
44. Brunser, O. et al., Effect of an infant formula with prebiotics on the intestinal microbiota
after antibiotic treatment, J. Pediatr. Gastroenterol. Nutr ., 40, 691, 2005.
45. Piirainen, L. et al., In school-aged children a combination of galacto-oligosaccharides
and Lactobacillus GG increases bifidobacteria more than Lactobacillus GG on its own,
Ann. Nutr. Metab ., 52, 204, 2008.
46. Fooks, L.J., and Gibson, G.R., Probiotics as modulators of the gut flora, Br. J. Nutr ., 88
Suppl. 1, S39, 2002.
47. Gibson, G.R., McCartney, A.L., and Rastall, R.A., Prebiotics and resistance to gastroin-
testinal infections, Br. J. Nutr ., 93 (Suppl. 1), S31, 2005.
48. Gibson, G.R. and Wang, X., Regulatory effects of bifidobacteria on the growth of other
colonic bacteria, J. Appl. Bacteriol ., 77, 412, 1994.
49. Anand, S.K., Srinivasan, R.A. and Rao, L.K., Antibacterial activity associated with
Bifidobacterium bifidum, II, Cult. Dairy Prod. J., Feb., 21, 1985.
50. Kunz, C. et al. Oligosaccharides in human milk: Structural, functional, and metabolic
aspects, Ann. Rev. Nutr ., 20, 699, 2000.
51. Tzortis, G. et al., A novel galactooligosaccharide mixture increases the bifidobacterial
population numbers in a continuous in vitro fermentation system and in the proximal
colonic contents of pigs in vivo , J. Nutr ., 135, 1726, 2005.
52. Shoaf, K. et al., Prebiotic galactooligosaccharides reduce adherence of enteropathogenic
Escherichia coli to tissue culture cells, Infect. Immun ., 74, 6920, 2006.
53. Macfarlane, G.T., Steed, H., and Macfarlane, S., Bacterial metabolism and health-related
effects of galacto-oligosaccharides and other prebiotics, J. Appl. Microbiol ., 104, 305,
2008.